论文部分内容阅读
近日,广药白云山公告了非公开发行A股股票预案,拟融资百亿元,该公告引发了资本市场的集体注目。根据白云山公布的方案,本次非公开发行对象为公司控股股东广药集团、添富-定增盛世专户66号资产管理计划、广州国资发展控股有限公司、广州国寿城市发展产业投资企业(有限合伙)、上海云锋新创投资管理有限公司拟设立的专项投资主体等5家特定对象。其均以现金认购,认购金额分别约为34.95亿元、5.05亿元、30亿元、25亿元、5亿元,
Recently, Guangzhou Baiyunshan announced the non-public offering of A shares plan to be raised 10 billion yuan, the announcement triggered the collective attention of the capital markets. According to Baiyun Mountain announced the program, the non-public offering of the object for the company’s controlling shareholder Guangzhou Pharmaceutical Group, Tim Fu - will increase the Spirit Asset Management Program No. 66, Guangzhou State-owned Development Holdings Ltd., Guangzhou State Urban Development Industrial Investment Enterprise (Limited partnership), Shanghai Yunfeng Venture Capital Management Co., Ltd. to be set up to invest in the five specific objects. They all subscribed in cash with subscription amounts of approximately RMB3,495 million, RMB550 million, RMB3 billion, RMB2.5 billion, RMB500 million,